Nautilus Biotechnology Stock Forecast
NASDAQ: NAUTIndustrialsBiotechnology: Laboratory Analytical InstrumentsUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Pre-market: 1.86 +2.20%
NAUT analyst consensus
Consensus (4 analysts)
strong_buy
Avg. price target
$3.83+110.44%
- Strong buy 0
- Buy 4
- Hold 0
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 4 Wall Street analysts covering Nautilus Biotechnology (2026-10-08), 4 rate the stock a buy or strong buy, 0 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "strong_buy". The average 12-month price target is $3.83, with a high estimate of $4.00 and a low estimate of $3.50. The average target implies upside of 110.4% from the current price of $1.82.
The spread between the highest and lowest targets is 14.3%, a relatively narrow range. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for NAUT.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 0 | 0% |
| Buy | 4 | 100% |
| Hold | 0 | 0% |
| Sell | 0 | 0% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-08.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $3.50 | +92.31% |
| Average target | $3.83 | +110.44% |
| High target | $4.00 | +119.78% |